AMA won't ban industry-funded education

Pharma marketers can sigh with relief. The American Medical Association won't be banning industry-funded CME this year, at least. At the association's annual meeting, delegates opted against a proposal to bar drugmakers from sponsoring residencies and fellowships, live or online CME, speakers' bureaus, travel and lodging, and the like. "Industry support of professional education has raised concerns that threaten the integrity of medicine’s educational function," the proposal stated.

Apparently, there were some concerns about a sponsorship ban, too. So the controversial measure, which would also have banned industry gifts and detailing at med schools, will get further review instead.

- read the Pharmalot item

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.